255 A Spanish Cost-utility Analysis of Nab-paclitaxel Compared to Conventional Paclitaxel Monotherapy for Pretreated Metastatic Breast Cancer: Results From the COSTABRAX Study
Keyword(s):
2015 ◽
Keyword(s):
1996 ◽
Vol 10
(5)
◽
pp. 504-521
◽
2013 ◽
Vol 13
(3)
◽
pp. 381-391
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):